Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gastroesophageal reflux within first year of life: What new recommendations from French National Authority for Health (HAS) tell us.
Jung C, Clouzeau H, Bouziane Nedjadi K, Peretti N, Lalanne A, Coopman S, Bellaiche M, Piloquet H, Fabre A, Ley D; French-speaking Pediatric Hepatology, Gastroenterology and Nutrition Group (GFHGNP). Jung C, et al. Among authors: lalanne a. Arch Pediatr. 2024 Nov 19:S0929-693X(24)00188-X. doi: 10.1016/j.arcped.2024.08.008. Online ahead of print. Arch Pediatr. 2024. PMID: 39567314 No abstract available.
Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study.
Sarter H, Crétin T, Savoye G, Fumery M, Leroyer A, Dauchet L, Paupard T, Coevoet H, Wils P, Richard N, Turck D, Ley D, Gower-Rousseau C; EPIMAD study Group. Sarter H, et al. Lancet Reg Health Eur. 2024 Oct 18;47:101097. doi: 10.1016/j.lanepe.2024.101097. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39478988 Free PMC article.
Divergent local and systemic antitumor response in primary uveal melanomas.
Lucibello F, Lalanne AI, Le Gac AL, Soumare A, Aflaki S, Cyrta J, Dubreuil L, Mestdagh M, Salou M, Houy A, Ekwegbara C, Jamet C, Gardrat S, Le Ven A, Bernardeau K, Cassoux N, Matet A, Malaise D, Pierron G, Piperno-Neumann S, Stern MH, Rodrigues M, Lantz O. Lucibello F, et al. Among authors: lalanne ai. J Exp Med. 2024 Jun 3;221(6):e20232094. doi: 10.1084/jem.20232094. Epub 2024 Apr 2. J Exp Med. 2024. PMID: 38563818 Free PMC article.
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
Borcoman E, Lalanne A, Delord JP, Cassier PA, Rolland F, Salas S, Limacher JM, Capitain O, Lantz O, Ekwegbara C, Jeannot E, Cyrta J, Tran-Perennou C, Castel-Ajgal Z, Marret G, Piaggio E, Brandely M, Tavernaro A, Makhloufi H, Bendjama K, Le Tourneau C. Borcoman E, et al. Among authors: lalanne a. Eur J Cancer. 2023 Sep;191:112981. doi: 10.1016/j.ejca.2023.112981. Epub 2023 Jul 11. Eur J Cancer. 2023. PMID: 37506588 Clinical Trial.
Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma.
Champiat S, Salaün H, Lucibello F, Scoazec JY, Besse B, Lalanne AI, Rouleau E, Metzger N, Saint-Ghislain M, Ryckewaert T, Gardrat S, Barnhill R, Cassoux N, Stern MH, Lantz O, de Koning L, Marabelle A, Rodrigues M. Champiat S, et al. Among authors: lalanne ai. JCO Precis Oncol. 2023 May;7:e2200363. doi: 10.1200/PO.22.00363. JCO Precis Oncol. 2023. PMID: 37224427 No abstract available.
Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.
Merlotti A, Sadacca B, Arribas YA, Ngoma M, Burbage M, Goudot C, Houy A, Rocañín-Arjó A, Lalanne A, Seguin-Givelet A, Lefevre M, Heurtebise-Chrétien S, Baudon B, Oliveira G, Loew D, Carrascal M, Wu CJ, Lantz O, Stern MH, Girard N, Waterfall JJ, Amigorena S. Merlotti A, et al. Among authors: lalanne a. Sci Immunol. 2023 Feb 3;8(80):eabm6359. doi: 10.1126/sciimmunol.abm6359. Epub 2023 Feb 3. Sci Immunol. 2023. PMID: 36735774
Development of a Core Outcome Set for Children Aged 1-18 Years with Gastroesophageal Reflux Disease.
Rexwinkel R, van Berge Henegouwen VWA, Singendonk MMJ, Krishnan U, VandenPlas Y, Strisciuglio C, Rosen R, Lalanne A, Rajindrajith S, Benninga MA, Tabbers MM; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Motility Working Group. Rexwinkel R, et al. Among authors: lalanne a. J Pediatr. 2022 Jun;245:129-134.e5. doi: 10.1016/j.jpeds.2022.01.043. Epub 2022 Feb 1. J Pediatr. 2022. PMID: 35120989 Free article.
39 results